New clues to spot a rare blood disorder

NCT ID NCT01713504

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked for new biological markers to help diagnose hypereosinophilic syndrome (HES), a rare condition where too many eosinophils (a type of white blood cell) cause damage. Researchers compared blood samples from 41 people with HES, those with other causes of high eosinophils, and healthy controls. The goal was to find markers that are easier and more informative than current tests, potentially leading to faster and more accurate diagnosis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to simpler and more reliable diagnostic tests for hypereosinophilic syndrome, helping doctors identify the disease sooner.
What could go wrong
This is a small, completed observational study focused on finding markers, not testing a treatment. The results may not lead to a practical test or change how the disease is managed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPEREOSINOPHILIC SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHRU, Hôpital Claude Huriez

    Lille, Nord, 59037, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.